[HTML] frontiersin.org

[HTML][HTML] Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

RE Malmström, BB Godman, E Diogene… - Frontiers in …, 2013 - frontiersin.org
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …
被引用次数：121 相关文章
[PDF] canberra.edu.au

[PDF][PDF] Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

H der Österreichischen Sozialversicherungsträger - researchsystem.canberra.edu.au
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …

Dabigatran-a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

RE Malmström, BB Godman… - Frontiers in …, 2013 - strathprints.strath.ac.uk
There are potential conflicts between authorities and companies to fund new premium
priced drugs especially where there are safety and/or budget concerns. Dabigatran, a new …

Dabigatran-a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

RE Malmström, BB Godman… - Frontiers in …, 2013 - pureportal.strath.ac.uk
There are potential conflicts between authorities and companies to fund new premium
priced drugs especially where there are safety and/or budget concerns. Dabigatran, a new …
[HTML] nih.gov

[HTML][HTML] Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

RE Malmström, BB Godman, E Diogene… - Frontiers in …, 2013 - ncbi.nlm.nih.gov
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …
[PDF] core.ac.uk

[PDF][PDF] Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

H der Österreichischen Sozialversicherungsträger - core.ac.uk
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …

Dabigatran-a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

RE Malmström, BB Godman, E Diogene… - Frontiers in …, 2013 - diva-portal.org
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …

Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

RE Malmström, BB Godman, E Diogene… - Frontiers in …, 2013 - eprints.lse.ac.uk
There are potential conflicts between authorities and companies to fund new premium
priced drugs especially where there are safety and/or budget concerns. Dabigatran, a new …
[PDF] researchgate.net

[PDF][PDF] Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

H der Österreichischen Sozialversicherungsträger - researchgate.net
Background: There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …

Dabigatran-a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.

RE Malmström, BB Godman, E Diogene… - Frontiers in …, 2013 - europepmc.org
Background There are potential conflicts between authorities and companies to fund new
premium priced drugs especially where there are safety and/or budget concerns …